From: Aortoesophageal fistula due to esophageal cancer: a case report of successful management
Study | Age (years) | Sex | Treatment for EC | Treatment for AEF | Treatment after AEF for EC | Outcome | Cause of death | Survival (days) | |
---|---|---|---|---|---|---|---|---|---|
1 | Kato [11] | 59 | Male | RT | TEVAR + enterostomy | NA | Death | Pneumonia | 135 |
2 | Ikeda [12] | 64 | Male | CT | TEVAR + bypass | NA | Alive | 180 | |
3 | Feezor [13] | 48 | Female | None | TEVAR | RT | Death | EC | 180 |
4 | Ishikawa [14] | 75 | Female | CRT | TEVAR | NA | Death | Graft infection | 90 |
5 | Ghosh [15] | 47 | Male | Esophageal stent | TEVAR | NA | Death | EC | NA |
6 | Nagata [16] | 58 | Male | NA | TEVAR | None | Death | NA | 60 |
7 | Wong [17] | 87 | Female | RT + esophageal stent | TEVAR | NA | Death | Tumor bleeding | 98 |
8 | Wong [17] | 58 | Male | CRT + esophageal stent | TEVAR | CT | Death | NA | 112 |
9 | Matsumoto [18] | 72 | Male | CRT | TEVAR | CRT | Death | EC | 124 |
10 | Matsumoto [18] | 56 | Male | CRT | TEVAR | None | Death | EC | 37 |
11 | Matsumoto [18] | 77 | Male | CRT | TEVAR | None | Death | Respiratory failure | 1 |
12 | Matsumoto [18] | 54 | Female | CRT | TEVAR | CRT, esophageal stent | Death | EC | 142 |
13 | Matsumoto [18] | 51 | Male | None | TEVAR | CT, CRT, esophagectomy | Death | EC | 384 |
14 | Matsumoto [18] | 60 | Male | None | TEVAR | None | Death | EC | 61 |
15 | Matsumoto [18] | 84 | Female | None | TEVAR | CRT, CT | Death | Hemorrhage | 527 |
16 | Matsumoto [18] | 62 | Male | CRT | TEVAR | CRT, CT | Death | EC | 155 |
17 | Matsumoto [18] | 65 | Male | CRT | TEVAR | None | Death | EC | 67 |
18 | Sasaki [19] | 67 | Male | CRT | TEVAR | NA | Death | N.A | 120 |
19 | Chen [20] | 55 | Male | CRT | EMB + TEVAR | NA | Death | EC | 120 |
20 | Chen [20] | 53 | Male | NA | EMB + TEVAR | NA | Death | EC | 210 |
21 | Chen [20] | 61 | Male | NA | TEVAR | NA | Alive | 180 | |
22 | Iwabu [21] | 69 | Male | CT → bypass → RT | TEVAR | None | Death | EC | 210 |
23 | Guerrero [22] | 69 | Male | CRT | TEVAR | None | Death | NA | 0 |
24 | Ćeranić [23] | 80 | Female | RT + esophageal stent | TEVAR | None | Death | Heart failure | 0 |
25 | Present study, 2023 | 64 | Male | CRT | TEVAR + esophagectomy | CRT | Alive | 270 |